Validation of a flow cytometry-based assay to assess C5aR receptor occupancy on neutrophils and monocytes for use in drug development
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation of a flow cytometry-based assay to assess C5aR receptor occupancy on neutrophils and monocytes for use in drug development
Authors
Keywords
-
Journal
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 90, Issue 2, Pages 177-190
Publisher
Wiley
Online
2015-06-17
DOI
10.1002/cyto.b.21260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - part III - analytical issues
- (2013) Shabnam Tanqri et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part II - preanalytical issues
- (2013) Bruce H. Davis et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - part V - assay performance criteria
- (2013) Brent Wood et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Optimal cellular preservation for high dimensional flow cytometric analysis of multicentre trials
- (2012) Amanda A.P. Ng et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Use of PD biomarkers to drive dose selection and early clinical decision making
- (2012) Nicola M Robas Bioanalysis
- Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function
- (2011) Walter C Olson et al. Journal of Translational Medicine
- Inhibiting the C5–C5a receptor axis
- (2011) Trent M. Woodruff et al. MOLECULAR IMMUNOLOGY
- MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
- (2011) Heleen Scheerens et al. ARTHRITIS RESEARCH & THERAPY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for the validation of flow cytometric testing during drug development: I instrumentation
- (2010) Cherie L. Green et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Recommendations for the validation of flow cytometric testing during drug development: II assays
- (2010) Denise M. O'Hara et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Stability of immunophenotypic markers in fixed peripheral blood for extended analysis using flow cytometry
- (2010) Cuc Davis et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Neutrophil function in inflammation and inflammatory diseases
- (2010) H. L. Wright et al. RHEUMATOLOGY
- Neutrophil kinetics in health and disease
- (2010) Charlotte Summers et al. TRENDS IN IMMUNOLOGY
- An Approach to the Validation of Flow Cytometry Methods
- (2009) Jo Cunliffe et al. PHARMACEUTICAL RESEARCH
- Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
- (2008) G Wells et al. ANNALS OF THE RHEUMATIC DISEASES
- Chemotactically active proteins of neutrophils
- (2008) B. K. Pliyev BIOCHEMISTRY-MOSCOW
- Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2
- (2008) Hyun Lee et al. IMMUNOLOGY AND CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More